Valuation: Takeda Pharmaceutical Company Limited

Market Cap 8,528B 52.43B 45.99B 42.45B 39.23B 74.36B 5,020B 75.85B 510B 198B 2,457B 197B 193B P/E 2027 *
44.3x
P/E 2028 * 28.4x
Enterprise Value 12,414B 76.32B 66.94B 61.8B 57.11B 108B 7,307B 110B 743B 289B 3,576B 287B 280B EV / Sales 2027 *
2.68x
EV / Sales 2028 * 2.61x
Free-Float
98.58%
Yield 2027 *
3.75%
Yield 2028 * 3.82%
1 day-0.97%
1 week+4.82%
Current month+4.71%
1 month+6.89%
3 months-6.75%
6 months+6.11%
Current year+11.64%
1 week 5,355
Extreme 5355
5,527
1 month 4,897
Extreme 4897
5,527
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer - 24/06/2026
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 60 01/06/2015
Director/Board Member 73 01/01/2019
Director/Board Member 48 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
07-01Free

Executive/Senior Manager

49,558 0.0031%
07-01Free

Chief Technology Officer

125,390 0.0079%
07-01Free

Executive/Senior Manager

45,140 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-0.97%+4.82%+22.88%+22.40% 52.94B
-1.15%-0.17%+53.99%+167.41% 1,084B
-1.63%-1.18%+66.32%+62.96% 634B
-1.01%-3.80%+31.75%+86.74% 447B
+0.18%-1.76%+29.04%+26.48% 330B
-6.22%-8.14%+28.87%+31.18% 295B
-1.27%-2.91%+27.42%+44.91% 285B
-0.93%-3.57%-27.74%-39.70% 218B
-1.65%-2.83%+22.60%+61.77% 199B
-1.62%+1.98%+18.22%+76.87% 169B
Average -1.63%+2.85%+27.34%+54.10% 371.28B
Weighted average by Cap. -1.55%+2.53%+38.62%+83.13%

Financials

2027 *2028 *
Net sales 4,630B 28.47B 24.97B 23.05B 21.3B 40.37B 2,726B 41.18B 277B 108B 1,334B 107B 105B 4,701B 28.9B 25.35B 23.4B 21.62B 40.99B 2,767B 41.81B 281B 109B 1,354B 109B 106B
Net income 184B 1.13B 992M 915M 846M 1.6B 108B 1.64B 11.01B 4.28B 52.97B 4.25B 4.15B 309B 1.9B 1.67B 1.54B 1.42B 2.7B 182B 2.75B 18.51B 7.19B 89.1B 7.14B 6.98B
Net Debt 3,886B 23.89B 20.95B 19.34B 17.87B 33.88B 2,287B 34.56B 233B 90.35B 1,119B 89.71B 87.74B 3,750B 23.06B 20.22B 18.67B 17.25B 32.7B 2,208B 33.36B 224B 87.21B 1,080B 86.58B 84.69B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
09/07/26 ¥5,398.00 -0.97% 2,773,800
08/07/26 ¥5,451.00 +0.06% 3,668,900
07/07/26 ¥5,448.00 -1.25% 3,488,200
06/07/26 ¥5,517.00 +2.95% 3,686,800
03/07/26 ¥5,359.00 +1.61% 4,074,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,451.00JPY
Average target price
6,106.87JPY
Spread / Average Target
+12.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock